Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
University Hospital details research in cancer vaccines
May 27th, 2009
According to recent research from Louvain, Belgium, "A significant proportion of patients with renal cell carcinoma (RCC) will experience recurrence or tumour progression after surgical treatment. Nowadays, several treatment options, including immunotherapy and targeted therapies, are available for management of advanced and metastatic RCC." "This paper aims to give an overview of the current treatment options for patients with advanced and metastatic RCC. Evidence acquisition: This paper is based on a presentation given at the 6th Meeting of the European Society of Oncological Urology 2009, held in Istanbul, Turkey. Data were retrieved from recent review articles,...
Source: Vaccine Weekly (2009-05-27)
|
